{"name":"AC Immune SA","slug":"ac-immune-sa","ticker":"","exchange":"","domain":"acimmune.com","description":"","hq":"Lausanne","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":16,"colorKey":"oncology","drugs":[{"name":"ACI-19764 at dose A1","genericName":"ACI-19764 at dose A1","slug":"aci-19764-at-dose-a1","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose A2","genericName":"ACI-19764 at dose A2","slug":"aci-19764-at-dose-a2","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose A3","genericName":"ACI-19764 at dose A3","slug":"aci-19764-at-dose-a3","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose A4","genericName":"ACI-19764 at dose A4","slug":"aci-19764-at-dose-a4","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose A5","genericName":"ACI-19764 at dose A5","slug":"aci-19764-at-dose-a5","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose A6","genericName":"ACI-19764 at dose A6","slug":"aci-19764-at-dose-a6","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose B1","genericName":"ACI-19764 at dose B1","slug":"aci-19764-at-dose-b1","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose B2","genericName":"ACI-19764 at dose B2","slug":"aci-19764-at-dose-b2","indication":"Other","status":"phase_1"},{"name":"ACI-19764 at dose B3","genericName":"ACI-19764 at dose B3","slug":"aci-19764-at-dose-b3","indication":"Other","status":"phase_1"},{"name":"ACI-24 high dose","genericName":"ACI-24 high dose","slug":"aci-24-high-dose","indication":"Other","status":"phase_1"},{"name":"ACI-24 low dose","genericName":"ACI-24 low dose","slug":"aci-24-low-dose","indication":"Other","status":"phase_1"},{"name":"ACI-24.060 at Dose A","genericName":"ACI-24.060 at Dose A","slug":"aci-24-060-at-dose-a","indication":"Other","status":"phase_1"},{"name":"ACI-24.060 at Dose B","genericName":"ACI-24.060 at Dose B","slug":"aci-24-060-at-dose-b","indication":"Other","status":"phase_1"},{"name":"ACI-24.060 at Dose C","genericName":"ACI-24.060 at Dose C","slug":"aci-24-060-at-dose-c","indication":"Other","status":"phase_1"},{"name":"ACI-24.060 at Dose D","genericName":"ACI-24.060 at Dose D","slug":"aci-24-060-at-dose-d","indication":"Other","status":"phase_1"},{"name":"ACI-35.030","genericName":"ACI-35.030","slug":"aci-35-030","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ACI-7104.056 at Dose A","genericName":"ACI-7104.056 at Dose A","slug":"aci-7104-056-at-dose-a","indication":"Alzheimer's disease","status":"phase_2"}]}],"pipeline":[{"name":"ACI-19764 at dose A1","genericName":"ACI-19764 at dose A1","slug":"aci-19764-at-dose-a1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose A2","genericName":"ACI-19764 at dose A2","slug":"aci-19764-at-dose-a2","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose A3","genericName":"ACI-19764 at dose A3","slug":"aci-19764-at-dose-a3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose A4","genericName":"ACI-19764 at dose A4","slug":"aci-19764-at-dose-a4","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose A5","genericName":"ACI-19764 at dose A5","slug":"aci-19764-at-dose-a5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose A6","genericName":"ACI-19764 at dose A6","slug":"aci-19764-at-dose-a6","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose B1","genericName":"ACI-19764 at dose B1","slug":"aci-19764-at-dose-b1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose B2","genericName":"ACI-19764 at dose B2","slug":"aci-19764-at-dose-b2","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-19764 at dose B3","genericName":"ACI-19764 at dose B3","slug":"aci-19764-at-dose-b3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACI-24 high dose","genericName":"ACI-24 high dose","slug":"aci-24-high-dose","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACI-24 low dose","genericName":"ACI-24 low dose","slug":"aci-24-low-dose","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACI-24.060 at Dose A","genericName":"ACI-24.060 at Dose A","slug":"aci-24-060-at-dose-a","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACI-24.060 at Dose B","genericName":"ACI-24.060 at Dose B","slug":"aci-24-060-at-dose-b","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACI-24.060 at Dose C","genericName":"ACI-24.060 at Dose C","slug":"aci-24-060-at-dose-c","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACI-24.060 at Dose D","genericName":"ACI-24.060 at Dose D","slug":"aci-24-060-at-dose-d","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACI-35.030","genericName":"ACI-35.030","slug":"aci-35-030","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACI-7104.056 at Dose A","genericName":"ACI-7104.056 at Dose A","slug":"aci-7104-056-at-dose-a","phase":"phase_2","mechanism":"ACI-7104.056 is a tau aggregation inhibitor.","indications":["Alzheimer's disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOQl9UcnR4V2FjZTRGc001V0ZEUXFvYVktMVVwZzFIWXlrWDVpWjYwVnRwek5VMjMyejZNUjlKSFR0NEdrNTFqZXd6Z090bTlIM2kzd2pnaXRvQjlaSWpYRmoyYkxfUjVwcjJzYnZoU2JmUDFoT0VXb3p2cjJsVE9QOUVYX2lsUzVCVkY3Tnc0Q2wzeGtr?oc=5","date":"2026-04-07","type":"pipeline","source":"Contract Pharma","summary":"AC Immune, Lilly Amend Morphomer Tau Alliance - Contract Pharma","headline":"AC Immune, Lilly Amend Morphomer Tau Alliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxObkwyUGVqQWxCeHdveTU1MVNmOXpPdFQyN0F3SDkzWVdiUmsxSGJnbF8tV19BOWhHcUhGWV81a2U4SnpZYngtMm1oRUl3aUZGNWdiMUpDRk1idHhrak1BYlYtQnRPc1djQmVocnUwc3lKNWVVRFAwSzRFZU94eDdqR1Z0aDRWeXFDS2ZHSlNOVVdhYnN3dUFfb1htdEJldk1faFJxakxB?oc=5","date":"2026-04-07","type":"deal","source":"The Pharma Letter","summary":"AC Immune amends license and collaboration deal with Lilly - The Pharma Letter","headline":"AC Immune amends license and collaboration deal with Lilly","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNZHRwMDBhZTNvcW9kNnZKNHVFX2dXckkxTnk0aGZER0dVWkNCTEZyNVFESnNtZ08zdkRydkV6OTYyOU9fMWVZNFl3VEE1SHQwR25ZcXhkc1RtZnphZF8tZFVPSUJ2T2hMelRqUGN3bFZoOW9hOEthWXhLSkhwLUhlOGVnUk9mN3Q2TV8yQVYxUkt4QWFBb1h2cHhNQy1IOWluWG9vY0NseVNuWFowNG5jYlZQLUNlWFFJeHlJUE1idy1sVm9OcXRINGxKeTd2dEttRHN1cU5VODJ1cDNXanJEcFN3?oc=5","date":"2026-02-17","type":"trial","source":"TipRanks","summary":"AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027 - TipRanks","headline":"AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNUTlBMXJCN0MzODBoT2JGaWdKaVZHSEh0NEY5RS0tXzY1MmlBeGszc2k1UkFDV25LRTlQNW56aVFMeWdMcGNkMGlIYTZXQlFGWURvYjhaRUYtUktSbkNJUy1BSGI5SjZVMkZHeEJmOFRqOThxazJFaUtMUldGWUM4TVdleDV3QnBjTWk3SGI5OU5qaWVRVUE?oc=5","date":"2026-02-12","type":"pipeline","source":"PharmTech.com","summary":"European Biotechs Impacting Treatment of Alzheimer’s Disease - PharmTech.com","headline":"European Biotechs Impacting Treatment of Alzheimer’s Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcEdjVElGQ01UMmNhSFR4MjBwMFVNZ29kMExFQWdWekRiYTdVbnZZRnM1QVBWLUdFNW5DamJ6OUszNzVTRXY3b3c3T1lpQ1hJYS1iaWhIYjFYU1h0RlNfbHg2VnBlRElnaHlTQmtoQXFGb05hRXc2TTNKSFVrNmg2clNEWUVvdW43R1Ryc1NiN0NnNWhqYlZLUl9xLXRHQ2JOWUJnVFEyZ2Z5dVU?oc=5","date":"2026-01-27","type":"pipeline","source":"BioCentury","summary":"2026 Catalysts: Psychiatry, epilepsy and neurodegeneration in focus - BioCentury","headline":"2026 Catalysts: Psychiatry, epilepsy and neurodegeneration in focus","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-10","type":"pipeline","source":"simplywall.st","summary":"AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy - simplywall.st","headline":"AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPYXczOFVCWGVLSzNUekUtUEtpM3hTZlFRa3d5R29DYTNweTlMU216V04wUm5lY256N1FpV09KanI1SkwzdXVPdWNaODlvRFhLMzVrc2ZnanhhTkhTNFRuY2tSUGd2TUx5UUZNWjAwY2dkeDNLY01pblVWMklQdzVPT2dDd3BDdWVHUXN4YU9fcTJoT2JKZEpKME1yQWNzRHZCaHRWVmw2LVBmZG90MzlDb3B4YUhnOHNvQXVQSnlZbGVxcUFKTkZXQTlXWG5FcWx3dEdVX0N5RjdUYTYxaktBT3Rn?oc=5","date":"2025-11-04","type":"earnings","source":"Quiver Quantitative","summary":"AC Immune SA Reports Q3 2025 Financial Results and Corporate Developments; Strategic Focus on Key Pipeline Assets - Quiver Quantitative","headline":"AC Immune SA Reports Q3 2025 Financial Results and Corporate Developments; Strategic Focus on Key Pipeline Assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxQZzF2OHU5WEYydktnTzltWVgtRzNiZThhbGJXOGQ0enEwZElGWEdxNFFLOGFiOW9pdzFJU3BIUHZyWHU0ejNpa29oZkR0cnQwMEp6dmt0SXBIMEo5Y0lQc1B4cXFRbGZOVl8yV1JoVVcySlFTVW1rR3E1eVg1N1ZYS3ZMN0FtYlA1NV9haTdfdm5OMW9SMkJXRUhFYXhjQkc2M3VVbjY3TWpSamFQZkI4WUlVaVp2RHUybFp6X0JOVllIclVTUWt5TVpwXzJwbHBsVzlfM193T2FQZ2dxUW1sUy13ZnN5UzN1cUw0bGZtTk5uU21ock9zOUdhckp1eEZsUy1mVVdKd2tvQQ?oc=5","date":"2025-11-04","type":"earnings","source":"Finansavisen","summary":"AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - Finansavisen","headline":"AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOUTZ6ckNXb1YzdDRIMm5WYXk3aHRwUElzb0NaVWJOeHpsVGt6ZmlYSGNvUVBhdXBNNUtDY19takFCckJhMDUyTEVnRTdaR0U0ZVdkSm9fWlcyWUhDQ2xnQlh6RTh1cGZaOU9yR0R5TEtIMVk4cXpPUDNvUXZQeUlUWU40djQ2eFItSXhLV256ZzlxRnBtc0I5Zm83MUZLNTN4X1lWNg?oc=5","date":"2025-09-30","type":"trial","source":"PharmaTimes","summary":"AC Immune’s Tau-targeting therapy shows promise in early Alzheimer’s trial - PharmaTimes","headline":"AC Immune’s Tau-targeting therapy shows promise in early Alzheimer’s trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE1FemFsajZSVmpwUm1Oa3c1M0QweDFLZHdOQU5JQUllQWNPV00wTWxaRTJERGdXbFQ0VnlOdUJKQVNCRnNRZEpBam1UbzNwSXF3THlqOEtWd2VhejQ?oc=5","date":"2025-07-27","type":"trial","source":"Being Patient","summary":"TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2025.02) - Being Patient","headline":"TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2025.02)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-11","type":"pipeline","source":"simplywall.st","summary":"AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st","headline":"AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxON2gxaHdoS0FWSUdCQlB1V1N4LThuQ2ktWERFQldnU0FoSVNGa1A3UzJOOVFNWWdjU1BvR1U0WFFVcHN0QWNadTFtb2dNZ0tDSkdqOWRLeHhhOFBzcnk0c284ZXhodko4LUdUaFRETllQY3VjNDc2amU4U25FcnotSkJlYk0xSkR5aHBRNDUxemVXalRmYmhsUWk1aGltbDNjMGNuSGsxaXU2cThuVXhhVVdMSWRlNzlEazJjZQ?oc=5","date":"2024-05-13","type":"trial","source":"Pharmaceutical Technology","summary":"Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy - Pharmaceutical Technology","headline":"Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy","sentiment":"neutral"}],"patents":[],"drugCount":17,"phaseCounts":{"phase_1":16,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}